Brief: Lumos Pharma Enters Into Controlled Equity Offering Sales Agreement Up To $50 Mln Of Shares Of Co's Common Stock
30/12/2020 22:36
Dec 30 (Reuters) - Lumos Pharma Inc LUMO.O :
* LUMOS PHARMA INC - ON DEC 30, ENTERED INTO A CONTROLLED
EQUITY
OFFERING SALES AGREEMENT UP TO $50.0 MILLION OF SHARES OF CO'S
COMMON STOCK
Source : (https://bit.ly/3aUJRbf)
Further company coverage: LUMO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lumos Pharma
See all newsLumos Pharma Inc expected to post a loss of 76 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Apple, Hershey, Dow
U.S. STOCKS ON THE MOVE-Magnite, Nvidia, Tesla
Lumos Pharma climbs on $38 mln go-private deal
Brief: Lumos Pharma Enters Into Definitive Merger Agreement With Double Point Ventures To Go Private Via A Tender Offer Of $4.25 Cash Per Share Plus Contingent Value Rights (Cvr)